322 related articles for article (PubMed ID: 22418036)
1. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
Fortuna A; Alves G; Falcão A; Soares-da-Silva P
Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
[TBL] [Abstract][Full Text] [Related]
3. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
4. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue.
Haslam IS; O'Reilly DA; Sherlock DJ; Kauser A; Womack C; Coleman T
Biopharm Drug Dispos; 2011 May; 32(4):210-21. PubMed ID: 21416475
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
6. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
7. A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method.
Watanabe E; Takahashi M; Hayashi M
Eur J Pharm Biopharm; 2004 Nov; 58(3):659-65. PubMed ID: 15451542
[TBL] [Abstract][Full Text] [Related]
8. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
9. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment.
Tannergren C; Bergendal A; Lennernäs H; Abrahamsson B
Mol Pharm; 2009; 6(1):60-73. PubMed ID: 19183105
[TBL] [Abstract][Full Text] [Related]
10. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
Zheng Y; Zuo Z; Chow AH
Int J Pharm; 2006 Feb; 309(1-2):123-8. PubMed ID: 16359834
[TBL] [Abstract][Full Text] [Related]
12. Exploring the role of different drug transport routes in permeability screening.
Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
[TBL] [Abstract][Full Text] [Related]
13. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
14. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations.
van de Kerkhof EG; Ungell AL; Sjöberg AK; de Jager MH; Hilgendorf C; de Graaf IA; Groothuis GM
Drug Metab Dispos; 2006 Nov; 34(11):1893-902. PubMed ID: 16914511
[TBL] [Abstract][Full Text] [Related]
15. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.
Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G
Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292
[TBL] [Abstract][Full Text] [Related]
16. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
17. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
18. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
Turco L; Catone T; Caloni F; Di Consiglio E; Testai E; Stammati A
Toxicol In Vitro; 2011 Feb; 25(1):13-20. PubMed ID: 20732406
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
20. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
Sugano K
Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
